HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette

This article was originally published in The Rose Sheet

Executive Summary

J.P. Morgan hired to explore strategic alternatives for Braun hair care, personal diagnostics and household products, including the potential sale of the businesses. Braun's hair removal and oral care lines are not included in the review; the products under consideration make up 35% of the business. Braun sales fell 9% to $1.58 bil. in 1999; the business has been a drain on Gillette's overall sales in recent quarters. The company recently hired Merrill Lynch to sell its stationery business, which also has been targeted as a divestiture candidate (1"The Rose Sheet" Feb. 21, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007698

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel